AbbVie Inc.
ABBV
$225.11
-$2.59-1.14%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -53.38% | -29.52% | -30.00% | -12.03% | -21.37% |
| Total Depreciation and Amortization | -1.27% | -2.89% | -3.40% | -3.59% | -4.77% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 151.54% | 107.08% | 126.57% | 38.04% | -29.04% |
| Change in Net Operating Assets | -17.71% | -4,190.77% | -244.90% | -198.90% | -160.39% |
| Cash from Operations | 26.34% | 3.46% | -27.70% | -17.66% | -35.29% |
| Capital Expenditure | -32.43% | -21.68% | -27.80% | -25.35% | -13.12% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 68.50% | -7.50% | -13.71% | -1,577.60% | -1,887.42% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -53.81% | 1,389.83% | 1,725.00% | 7,555.56% | 328.57% |
| Cash from Investing | 64.28% | -1.58% | -7.83% | -936.34% | -1,091.67% |
| Total Debt Issued | -40.96% | -42.17% | -62.01% | -- | -- |
| Total Debt Repaid | -36.66% | -26.27% | -58.60% | -252.40% | -15.72% |
| Issuance of Common Stock | -42.98% | -32.35% | -40.91% | 18.89% | 16.34% |
| Repurchase of Common Stock | 1.33% | -0.60% | -0.30% | 13.39% | 31.42% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -5.50% | -5.23% | -4.96% | -4.61% | -4.61% |
| Other Financing Activities | 147.00% | 121.43% | 108.35% | 94.34% | 90.11% |
| Cash from Financing | -450.88% | -482.12% | -8,093.36% | 69.74% | 87.51% |
| Foreign Exchange rate Adjustments | -475.00% | 105.00% | -80.95% | -1,400.00% | -20.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 73.00% | -252.44% | -213.53% | -301.77% | -514.43% |